ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The company has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of IMMUPHARMA PLC.
IMMUPHARMA PLC business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of IMMUPHARMA PLC are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of IMMUPHARMA PLC , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of IMMUPHARMA PLC including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of IMMUPHARMA PLC and all latest updates of the company are provided.
The 2025 version of IMMUPHARMA PLC report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 IMMUPHARMA PLC- Key Facts
2.2 IMMUPHARMA PLC- Geographic Locations
2.3 IMMUPHARMA PLC- Subsidiaries and Affiliates
2.4 IMMUPHARMA PLC- Business Divisions
2.5 IMMUPHARMA PLC- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. IMMUPHARMA PLC Strategic Analysis Review
3.1 IMMUPHARMA PLC- Key Strategies
3.2 IMMUPHARMA PLC- Company Outlook Statement
3.3 IMMUPHARMA PLC- SWOT Analysis
3.3.1 IMMUPHARMA PLC- Key Strengths
3.3.2 IMMUPHARMA PLC- Key Weaknesses
3.3.3 IMMUPHARMA PLC- Potential Opportunities
3.3.4 IMMUPHARMA PLC- Potential Threats
3.4 IMMUPHARMA PLC- Key Competitors
4. Business Description of the Company
4.1 IMMUPHARMA PLC- Business Overview
4.2 IMMUPHARMA PLC- Operations by Segment
5 Products and Services Details
5.1 IMMUPHARMA PLC- Key Products
5.2 IMMUPHARMA PLC- Key Service Areas
5.3 IMMUPHARMA PLC- Key Brands
6 Company Developments
6.1 IMMUPHARMA PLC- Company History
6.2 IMMUPHARMA PLC- Latest Developments
7 Financial Analysis
7.1 IMMUPHARMA PLC- Income Statements
7.2 IMMUPHARMA PLC- Balance Sheet
7.3 IMMUPHARMA PLC- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 IMMUPHARMA PLC- Direct Competitors
8.2 IMMUPHARMA PLC- Competitor Financial Ratios comparison
8.3 IMMUPHARMA PLC- Competitor Stock Charts Comparison
8.4 IMMUPHARMA PLC- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!